Skip to main content
B

Beijing Kawin Technology Share-Holding Co., Ltd. — Investor Relations & Filings

Ticker · 688687 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688687

About Beijing Kawin Technology Share-Holding Co., Ltd.

Beijing Kawin Technology Share-Holding Co., Ltd. is a biopharmaceutical enterprise focused on the research, development, and commercialization of innovative therapeutic solutions. The company specializes in the treatment of viral infections, particularly chronic hepatitis C, as well as oncology and immunological disorders. Its product portfolio includes recombinant human interferon α2b, ribavirin, and advanced direct-acting antiviral (DAA) therapies. Kawin Technology leverages integrated platforms for protein engineering and chemical drug synthesis to address unmet medical needs. The firm maintains a comprehensive value chain encompassing drug discovery, clinical development, and large-scale manufacturing. By prioritizing scientific innovation, the company aims to provide high-quality, accessible treatments for complex diseases, establishing a significant presence in the specialized pharmaceutical market.

Recent filings

Filing Released Lang Actions
凯因科技2025年度“提质增效重回报”行动方案评估报告暨2026年度“提质增效重回报”行动方案
Regulatory Filings Classification · 0% confidence The document is a standalone “Action Plan Evaluation Report” covering the company’s execution of its 2025 action plan and laying out its 2026 plan. It is not an AGM presentation, annual or interim financial report, earnings release, call transcript, or any other narrowly defined filing. It is a general corporate report on governance, investor returns, R&D, and future strategy, which does not fit any specific category. Therefore, it falls into the fallback category of miscellaneous regulatory announcement.
2026-04-24 Chinese
凯因科技2025年度独立董事述职报告（杜臣）
Governance Information Classification · 1% confidence The document is titled “2025年度独立董事述职报告” and consists of an independent director’s annual work report, detailing governance processes, board/committee activities, attendance, compliance with laws and listing rules, and recommendations. It is not a financial report, capital notice, or management change announcement, but a corporate governance disclosure. This aligns with the Governance Information category (CGR).
2026-04-24 Chinese
凯因科技关于公司使用部分闲置自有资金购买理财产品的公告
Regulatory Filings Classification · 1% confidence The document is a board‐approved public announcement detailing the company’s use of idle self‐owned funds to purchase financial products. It does not report financial results (ER/IR/10-K), dividend (DIV), share issues (SHA), share repurchases (POS), major shareholdings (MRQ), legal matters (LTR), M&A (TAR), or other specific transactions. It is not a report itself but a standalone regulatory announcement of a corporate transaction/decision. This fits the fallback category “Regulatory Filings” (RNS).
2026-04-24 Chinese
凯因科技2025年度董事会审计委员会履职情况报告
Governance Information Classification · 1% confidence The document is a standalone “2025年度董事会审计委员会履职情况报告” (2025 Annual Board Audit Committee Performance Report) filed by Beijing KAIN Technology. It is not an earnings release, dividend announcement, share issuance notice, or regulatory delisting. It is a detailed report on the audit committee’s membership, meeting activities, oversight of internal/external audits, and governance processes—i.e., a governance‐related document. Therefore, it best fits the Governance Information category (CGR).
2026-04-24 Chinese
凯因科技关于续聘2026年度审计机构的公告
Regulatory Filings Classification · 1% confidence The document is an official corporate announcement (公告) regarding the reappointment of the external audit firm for the 2026 fiscal year. It is not an audit report itself (so it doesn’t fit AR), nor any other specific category (e.g., management change, dividends, or a published report). It is a regulatory announcement under listing rules, serving as a general regulatory filing. Therefore, it is best classified under the fallback category RNS.
2026-04-24 Chinese
凯因科技2025年度内部控制评价报告
Audit Report / Information Classification · 1% confidence The document is a formal "内部控制评价报告" (internal control evaluation report) issued by the company describing its internal control assessment over financial and non-financial reporting. It is not an Annual Report (10-K) nor a short announcement. It is a standalone regulatory audit-style report on internal controls, fitting under standalone audit/information filings. Therefore it maps to the Audit Report / Information category (AR).
2026-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.